Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS su...
Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemr...
Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Ph...
Histogenics Corporation, a NASDAQ-listed regenerative medicine company focused on developing and commercializing product...
Tokyo: Corneal endothelial precursor cell transplantation methodology, employing a Nanocomposite gel sheet has been awar...
Dublin-headquartered Allergan plc has announced that the Japanese Ministry of Health, Labour and Welfare has approved an...
Singapore:Â Microfluidics expert Dolomite is now a licensee of Japan Science and Technology Agency (JST) under JST's m...
Singapore: Japan's Daiichi Sankyo has decided to reorganize three of its Japanese supply chain subsidiaries, Daiichi San...
Singapore: Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo) has announced its decision to close the Hiratsuka ...
Singapore:Â Thailand's flagship biotechnology organization, BIOTEC, NITE Biological Resource Center (NBRC) of Japan an...
Singapore: Japan-headquartered Ajinomoto has entered into a definitive agreement to acquire Althea Technologies, a US-ba...
Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attr...
Singapore: Leading independent healthcare analyst, Datamonitor Healthcare, has revealed in their latest research that th...
Tokyo:Â Astellas Pharma EMEA, the regional headquarters of Japan's Astellas Pharma Inc. for Europe, the Middle East an...
Singapore: India's Tamil Nadu Agricultural University (TNAU) professor Natesan Senthil and a Japanese professor have tog...
Singapore: Eisai and Sysmex Corporation jointly announced that the two companies have entered into a comprehensive non-e...
Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...
Copenhagen-based ALK has announced that its partner in Japan, Torii Pharmaceutical Co Ltd, has reported positive results...
Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in...
Singapore: Infraredx, a medical device company committed to advancing the diagnosis and management of coronary artery an...
Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibi...
Singapore: Japanese company Otsuka Pharmaceutical and H Lundbeck, Denmark-based company, have outlined co-promotion plan...
Singapore: Novartis' Alcon expanded the recall of its intraocular lenses in Japan, pushing the number of affected units ...
Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the ne...
Singapore: Eisai has entered into an exclusive license agreement with HUYA Bioscience International to develop and marke...
